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Abstract
Integrins are metalloproteins whose receptor function is dependent on the interplay between Mg2 and Ca2. Although the
specificity of the putative divalent cation binding sites has been poorly understood, some issues are becoming clearer and this
review will focus on the more recent information. The MIDAS motif is a unique Mg2/Mn2 binding site located in the
integrin K subunit I domain. Divalent cation bound at this site has a structural role in coordinating the binding of ligand to
the I domain containing integrins. The I-like domain of the integrin L subunit also has a MIDAS-like motif but much less is
known about its cation binding preferences. The N-terminal region of the integrin K subunit has been modelled as a
L-propeller, containing three or four ‘EF hand’ type divalent cation binding motifs for which the function is ill defined. It
seems certain that most integrins have a high affinity Ca2 site which is critical for KL heterodimer formation, but the
location of this site is unknown. Finally intracellular Ca2 fluxes activate the Ca2 requiring enzyme, calpain, which regulates
cluster formation of leucocyte integrins. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction: general integrin structure
The integrins are a family of cell surface receptors,
which mediate adhesive interactions. They recognise
multiple protein ligands, which are either extracellu-
lar matrix proteins or other cell surface receptors
such as members of the immunoglobulin superfam-
ily. All integrins are heterodimeric transmembrane
glycoproteins that are composed of non-covalently
associated K and L subunits. To date, 18 distinct
integrin K subunits and eight distinct integrin L sub-
units have been identi¢ed, which give rise to more
than 20 di¡erent KL complexes.
Electron microscopy studies show that the N-ter-
minal portions of both subunits contribute to a glob-
ular ‘head’ domain, which is connected to the cell
membrane by two stalks corresponding to the C-ter-
minal portions of the extracellular domains [1,2].
There is now more structural detail available of the
globular head, which is composed of three types of
subdomains. All integrin K subunits have seven ho-
mologous 60 amino acid repeats at the N-terminus,
which have been predicted to fold into a L-propeller
structure [3]. In this model the seven repeats form
L-sheets (named W1^7) and are arranged like blades
on a propeller (Fig. 1).
Nine integrin K subunits incorporate an addition-
al, autonomously folding domain of approx. 200
amino acids, which is termed the I (inserted) domain.
The I domain is inserted between repeats 2 and 3
(W2,3) and belongs to a family of homologous pro-
teins of which von Willebrand factor A domain is the
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prototype (reviewed in [4]). The I domain is the only
integrin domain for which detailed structural infor-
mation is currently available. The crystal structures
of the I domains from four integrins are known and
reveal a dinucleotide binding fold composed of a
central L-sheet surrounded by seven K helices [5^8]
(Fig. 2). The K subunit I domain is predicted to sit
on ‘top’ of the putative L-propeller domain, inserted
into a loop between L-sheets 2 and 3 (W2,3) [3].
All integrin L subunits have a highly conserved
region of approx. 240 amino acids near their N-ter-
minus, which has been predicted to adopt a fold
similar to the K subunit I domain [5,9], and will be
termed the ‘L I-like’ domain. A prediction that the L
I-like domain interacts with the L-propeller domain
of the K subunit has come from two recent studies
that mapped mAb epitopes [10,11]. Both studies con-
clude that the L I-like domain contacts the L-propel-
ler domain at the boundary between repeats 2 and 3
(W2,3) (Fig. 3). Thus both I and I-like domains as-
sociate with the L-propeller domain at a similar lo-
cation, with the K I domain looping out from the top
of the L-propeller and the L I-like domain meeting
the side of the L-propeller. By this coincidence of
location both I domains are, therefore, closely asso-
ciated, with the bottom of the K I domain potentially
in contact with the top of the L I-like domain.
2. Functional e¡ects of divalent cations on the integrin
ectodomain
Integrins on resting cells (particularly leucocytes)
do not bind well to their ligands, but are rapidly and
reversibly activated by diverse cellular agonists. Ac-
tivation of integrins has been associated with confor-
mational changes in the extracellular domains lead-
ing to an increase in the a⁄nity for ligand binding,
as well as with lateral association of integrins into
clusters, which increases the avidity of the interaction
with ligand [12]. All integrin-ligand interactions are
dependent on divalent cations, but divalent cations
have multiple e¡ects including suppression, enhance-
ment and modi¢cations of the ligand binding activ-
ity. For many integrins, Mg2 and Mn2 can induce
conformational changes (detected by special ‘activa-
tion’ reporter mAbs) that correlate with higher a⁄n-
ity binding to ligand, but Ca2 often has an inhib-
itory e¡ect on ligand binding. For example, for the
integrins K2L1 [13], LFA-1 [14] and KvL3 [15] an
increase in integrin a⁄nity for ligand brought about
by Mg2 requires chelation of Ca2, usually with the
use of EGTA. On the other hand, the well-charac-
terised LFA-1 activation mAb NKI-L16 marks clus-
tered integrin in a Ca2 sensitive manner [16].
There are several divalent cation binding motifs
common to all integrins (Fig. 1). The putative L-pro-
Fig. 1. Schematic representation of the domain structure of in-
tegrins. The seven homologous repeats of the K subunit are des-
ignated by numbers 1^7. In those integrins that contain an I
domain this domain is inserted between repeat domains 2 and
3 of the K subunit. Stars denote putative Ca2 binding sites. I
domain containing integrins have three of these sites (5^7) and
non-I domain containing integrins have four of these sites
(4^7).
Fig. 2. The crystal structure of the I domain from the integrin
KM subunit [5]. The domain adopts a dinucleotide binding fold
with a central L-sheet surrounded by seven amphipathic helices.
A single cation binding site, termed MIDAS, is located on top
of the fold. The bound cation at the top of the fold is shown.
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peller domain of the K subunit contains three (for I
domain containing integrins) or four (for non-I do-
main containing integrins) cation binding motifs
which are deemed to bind Ca2 ; the K subunit I
domain contains a unique metal binding site speci¢c
for Mg2 and Mn2 ; and the conserved I-like do-
main of the L subunit contains a similar cation bind-
ing motif for which the speci¢city is currently not
clearly established. Thus for each type of integrin
there are ¢ve divalent cation binding motifs.
It has been known for some time that extracellular
Ca2 can regulate the function of integrins but the
Ca2 binding sites on integrins are poorly de¢ned. So
far, at least two distinct classes of Ca2 binding sites
that di¡er in their a⁄nity for the metal ion have been
characterised. An equilibrium dialysis study with pu-
ri¢ed platelet integrin KIIbL3 has provided evidence
for one high a⁄nity (WM) and 3^4 low a⁄nity (mM)
Ca2 sites [17]. For K5L1 integrin [18] and for L3
integrins [19] a high a⁄nity Ca2 site (WM) promotes
binding to ligand and a low a⁄nity site appears to
compete allosterically with a Mg2 occupied site. A
similar two site model for Ca2 regulation of puri¢ed
LFA-1 binding to ICAM-1 has been proposed [20].
Occupation of a high a⁄nity Ca2 site (WM range) is
also required for Mg2-activated K2L1-mediated ad-
hesion to collagen [21]. Early work with KIIbL3 sug-
gested that heterodimer formation depends on a high
a⁄nity Ca2 site [22]. The fact that a high a⁄nity
Ca2 site exists for a range of integrins suggests a
possible common role in heterodimer formation. A
further implication is that Ca2 bound to the high
a⁄nity site is necessary for ligand binding. This re-
view will concentrate on the role of Ca2 in integrin
function. Unfortunately none of the binding sites for
Ca2 have been unequivocally assigned, but their
locations can be speculated upon.
3. MIDAS site of the K subunit I domain
The crystal structures of the I domains from the
KL, KM, K1 and K2 subunits have been solved and
invariably show a common structural motif (see
above). The ¢rst crystal structure of an I domain
(from KM) revealed a novel Mg2/Mn2 binding
site [5]. This single conserved metal binding site,
termed metal ion-dependent adhesion site (MIDAS),
is located in the upper face of the I domain, most
distal to the face that connects the I domain to the
proposed L-propeller domain. The metal coordina-
tion is provided by a highly conserved motif of
Asp-X-Ser-X-Ser and a Thr and Asp residue from
non-contiguous regions. These ¢ve I domain residues
coordinate the metal ion either directly or via water
molecules. Mutagenesis studies showed that the
MIDAS motif and the solvent-exposed side chains
nearby are required for ligand binding, indicating
that the surface containing the metal binding site
provides a contact region for ligand.
For the KM I domain two di¡erent conformations
have been crystallised that di¡er in the MIDAS met-
al ion coordination as well as in the orientation of
the C-terminal K7 helix [5,23^25]. These two confor-
mations have been linked to two functional states
(active or inactive) of this I domain but it has been
unclear whether the bound cation played a structural
or a conformation altering role. The recent elucida-
tion of the ¢rst crystal structure of an I domain
bound to a ligand (I domain from K2 bound to a
Fig. 3. Cartoon structure of an I domain containing integrin.
The K subunit I domain is predicted to lie on top of the puta-
tive L-propeller domain and is inserted between L-sheets 2 and
3. The L subunit I-like domain is predicted to contact the side
of the L-propeller domain at the second and third L-sheet.
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triple helical collagen peptide) shows that the sixth
metal-coordination site is occupied by a glutamic
acid from the ligand [26]. This study provides the
¢rst de¢nitive evidence for a central and direct struc-
tural role for the metal ion in binding ligand. A
comparison of the K2 I domain with and without
bound ligand revealed similar changes in conforma-
tion as have been observed between the two crystal
forms of the KM I domain. Thus one model would
be that the binding of ligand to the I domain
MIDAS brings about a shift in divalent cation coor-
dination. This change in cation coordination in turn
causes conformational changes in the I domain itself
with a major movement in the K7 helix [26,27].
The inhibiting e¡ect of Ca2 on the Mg2/Mn2-
induced a⁄nity increase in I domain containing in-
tegrins could in principle be explained by metal ion
competition at the ligand binding I domain MIDAS
motif. One report provides evidence that Ca2 can
inhibit Mn2 binding to the isolated LFA-1 I domain
[28]. However, we ¢nd that Ca2 at concentrations
up to 10 mM has no e¡ect on Mg2-induced binding
of isolated I domain to ICAM-1 (P. Stanley, unpub-
lished data). This lack of e¡ect of Ca2 on the ligand
binding activity of isolated I domain has also been
demonstrated for the K2L1 I domain [21]. Finally,
the metal ion coordination geometry at the MIDAS
is such that the larger Ca2 ion is predicted not to
bind to this motif [5,26]. Therefore it may be tenta-
tively concluded that the I domain does not bind
Ca2 and will not provide the site necessary for het-
erodimer formation nor the competitive inhibitory
site for Mg2/Mn2 binding.
4. I-like domain of the L subunit
Less is known about the structure and function of
the L I-like domain. Although it is now thought to
fold similarly to the K I domain [5,9], it has only
recently been synthesised as an isolated domain
[29,30]. Several residues with oxygenated side chains
are highly conserved and have invariably been found
to be important for ligand binding [31^34]. Three of
these correspond to the Asp-X-Ser-X-Ser motif of
the I domain MIDAS motif. This MIDAS-like metal
binding motif of the L I-like domain, like the
MIDAS in the K I domain, is located at the ‘top’
of the domain in the predicted structure. Currently
there is little evidence about the speci¢city for cations
of this MIDAS-like motif. Terbium luminescence
studies have suggested formation of a transient ter-
nary complex between L3 I-like domain, cation and
ligand RGD which results in cation displacement
[35]. Results with the isolated L1 I-like domain are
in agreement with this cation displacement model
[30]. If cation loss is the ¢nal result of L I-like do-
main interaction with ligand then the properties of
this MIDAS-like motif di¡er from the K subunit I
domain MIDAS.
Evidence from CD spectra and NMR relaxation
indicates that the isolated L I-like domain from the
L1 integrin binds Mg2/Mn2 with WM a⁄nity but
has only low a⁄nity for binding Ca2 [30]. RGD
peptide binding to the isolated L I-like domain
from the L3 integrin is promoted at 0.1 mM Ca2
but not at 1 mM Ca2 [29]. This suggests that this
domain contains both the high a⁄nity Ca2 binding
site which promotes ligand binding as well as the low
a⁄nity Ca2 binding site which is inhibitory for li-
gand binding. On the other hand, in the context of
the whole integrin, mutations of putative MIDAS
residues in the L3 I-like domain, which a¡ect
Mg2/Mn2 binding, leave the inhibitory Ca2 bind-
ing site intact [34]. This suggests that the inhibitory
Ca2 binding site is distinct from the MIDAS-like
motif.
Further insight into the function of the L I-like
MIDAS motif has come from some naturally occur-
ring mutations. Leucocyte adhesion de¢ciency
(LAD) syndrome and Glanzmann’s thrombasthenia
(GT) are inherited integrin de¢ciency syndromes in
which mutations in the L subunit genes result in a
failure of the L subunit to pair successfully with the
respective K subunit. Analysis of the missense muta-
tions of these syndromes has been informative in that
the majority are located within the L I-like domain
and indeed cluster around the MIDAS-like motif
[36]. This suggests that these residues surrounding
the MIDAS-like motif of the L I-like domain are
involved in heterodimer formation. Two disease mu-
tants which have been mapped to the MIDAS-like
motif itself in L2 and L3 integrins disrupt integrin
function but not heterodimer formation [37,38].
The same holds true for mutagenesis of the L I-like
MIDAS residues in several integrins. Thus, although
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the MIDAS-like motif of the L I-like domain itself
clearly has a role in integrin function it is probably
not directly involved in heterodimer formation.
In summary, the L I-like domain has a fundamen-
tal role in regulating integrin function which depends
on its MIDAS-like motif, for which the nature of the
bound cation is uncertain. This domain may also
contain the inhibitory low a⁄nity Ca2 site but evi-
dence suggests that this Ca2 site is distinct from the
MIDAS-like motif.
5. EF hand or W4^7 sequences
The N-terminal repeating domain structure (W1^7
in the putative L-propeller) is a key feature of the K
subunit. Of the seven repeats, the ¢nal four in some
integrins (W4^7) and three in all integrins (W5^7)
have features which resemble the classical EF hand
and, therefore, have been deemed to bind Ca2.
However, the lack in these sequences of the crucial
3z position of the EF hand has suggested that, if
these sequences bind Ca2, the motif may be modi-
¢ed from the standard helix-loop-helix. With the
modelling of the repeating domains into a L-propel-
ler structure, the Ca2 binding sequences (W4^7)
now better resemble the hitherto novel type of
Ca2 binding site found in the bacterial galactose
binding protein (GBP) [39]. In GBP the metal ion
is held in place through coordination with a nine
residue loop which is preceded by a L turn and fol-
lowed by a L strand rather than being enclosed by
two K helices. It is attractive to speculate that the
four KIIbL3 sites which bind Ca2 in the mM range,
detected in the equilibrium dialysis studies of Rivas
and Gonzalez-Rodriguez [17], might be located in the
W4^7 sequences. Some evidence that the sites do
bind Ca2 comes from the mapping of a Ca2 sensi-
tive epitope to W5 and W6 [40].
Because the W4^7 Ca2 binding motifs are posi-
tioned at the bottom of the L-propeller, opposite to
the face where ligand binding is thought to occur, it
has been suggested that they will not be involved
directly in ligand binding [3,40]. There has, however,
been some evidence that the isolated domains con-
taining these putative Ca2 binding motifs can func-
tion in ligand binding. The repeat domains contain-
ing the W4^7 cation binding motifs from K5L1 have
been made as soluble protein, found to bind Ca2
and Mg2 as well as ligand ¢bronectin, and, inci-
dently, to contain 30^35% K helix, reminiscent of
the more traditional EF hand [30,41]. A similar re-
gion (W5^7) also positively in£uences ICAM-1 bind-
ing by LFA-1 [42] and collagen binding by K2L1
[43]. In the second of these studies, the presence of
the W5 domain enhanced collagen binding by the I
domain, but it was unclear whether the e¡ect was
dependent upon divalent cation. However, mutation
of Asp 272 and Asp 274 (positions 1 and 3 of the
putative EF hand), eliminated the W5-mediated en-
hancement.
In W5^7 of the K4L1 integrin K subunit, the resi-
dues which correspond to position 3 in cation coor-
dination by EF hands have been mutagenised [44].
This mutagenesis had no impact on the ability of this
integrin to bind its ligand VCAM-1 or to form in-
tegrin clusters but the transfected cells with mutated
EF hands were more easily detached when subjected
to shear £ow conditions [45]. Furthermore, each in-
dividual mutation had an equivalent e¡ect suggesting
a cooperative mechanism. Integrin K4L1 engages in
lateral interaction on the membrane with a class of
proteins which span the cell membrane four times
and are therefore termed ‘tetraspannin’. Pairing of
integrin with these proteins is thought to promote
integrin-mediated signalling and migration [46].
However, the K4 mutants were unable to associate
with the tetraspan protein CD81 [47]. This result
suggests that these W5^7 putative metal ion binding
sites may have a role, not in ligand binding by in-
tegrins, but rather in the cis interactions by which
integrins engage with other membrane proteins [46].
This attractive suggestion for the function of these
sites is made less certain by the ¢nding that divalent
cations were not necessary for this association, which
is stable in EDTA. Furthermore, similar ‘EF hand’
mutations do not in£uence the CD151/K3L1 interac-
tion, although the strength of association between
this particular tetraspannin/integrin pair is exception-
ally strong [48].
A conclusion from the above examples might be
that the ‘EF hand’ sequences do appear to in£uence
integrin function but not necessarily through the
ability of these sequences to bind divalent cation. A
resolution to the con£icting evidence for a role for
Ca2 in these domains might be that, in the context
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of these domains, Ca2 is performing a structural
role which is not always essential.
6. A role for intracellular Ca2+ in integrin function
It has been known for some time that intracellular
Ca2 is involved in the intracellular (‘inside out’)
signalling that leads to integrin-mediated adhesion.
For example, LFA-1-mediated adhesion to ICAM-
1, when stimulated by agonists such as phorbol ester,
is inhibited by the intracellular Ca2 chelator BAP-
TA [49]. Agonists which mobilise intracellular Ca2,
such as thapsigargin, also promote LFA-1-mediated
adhesion. Di¡erent methods of stimulating inside-out
signalling all induce LFA-1 adhesion by allowing
clustering of LFA-1 in the membrane by a pathway
which involves the Ca2 dependent protease calpain
[50]. The results are consistent with a model in which
LFA-1 on resting lymphocytes is tethered to the cy-
toskeleton and following a Ca2 £ux, calpain is acti-
vated and cleaves this tether, freeing LFA-1 to be-
come more mobile in the membrane with cluster
formation as the end result (Fig. 4). This model al-
lows for the selective clustering of integrin at points
of contact between a lymphocyte and a target cell,
just where an increase in the strength of adhesion is
needed (termed an avidity increase). Identifying the
intracellular proteins cleaved by calpain has been
di⁄cult because of this enzyme’s many intracellular
targets. Limiting the list to those associated with ad-
hesion, calpain cleaves cytoskeletal proteins such as
K-actinin, ¢lamin, talin and actin as well as signalling
proteins such as FAK, PTP-1B and PKC [51]. Work-
ing with neutrophils, Pavalko and associates found
that, in resting conditions, talin binds to L2 integrin.
Upon stimulation with fMLP, talin is cleaved by
calpain and the cleaved form is no longer able to
associate with integrin [52]. This could potentially
be a mechanism to allow movement of integrin in
the membrane. It remains to be proven whether
this observation will hold true for integrins on other
cell types.
In migrating CHO cells transfected with L1 and L3
integrins, results with inhibitors indicate a role for
calpain in cleaving integrin-mediated adhesion at
the rear of the cell leading to rear detachment which
is required for translocation of the cell body in a
forward direction [53,54]. Thus the Ca2-activated
enzyme calpain has a role in the regulation of integ-
rin-cytoskeletal interactions and thereby in£uences
integrin-ligand binding and cell adhesion.
7. Concluding remarks
Ca2 has several types of roles in integrin function.
Because Ca2 sites are di⁄cult to predict [55], uncer-
tainty exists as to the location of all the functional
Ca2 sites within a typical integrin. The present evi-
dence suggests that the ‘EF hand’ domains, W4^7,
represent mM Ca2 sites which basically have a
structural role for the putative L-propeller module.
The other key Ca2 sites may be located in the L I-
like domain. Low concentrations of Ca2 promote
RGD binding to the isolated L3 I-like domain and
this domain also seems to include a low a⁄nity
(mM) Ca2 site which inhibits ligand binding [29].
Finally the high a⁄nity Ca2 site upon which heter-
odimer formation ^ and consequently ligand binding
Fig. 4. Model for the role of intracellular Ca2 in inducing in-
tegrin-mediated adhesion. Ca2 £ux into the cell activates the
protease calpain which then cleaves the attachment between the
integrin and the cytoskeleton (1). This allows the integrin to
move in the membrane and gather in clusters which may (2) or
may not (3) become tethered to the cytoskeleton again.
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^ depends lacks further de¢nition. If this site has a
direct role in KL association, then it is probably not
located in the globular head domain region as the
electron microscopy pictures of Hantgan and col-
leagues show these domains to be 7 nM apart in
the active integrin [2]. More high resolution struc-
tures similar to that of the K2 I domain with collagen
peptide [26] are badly needed for further progress in
resolving these issues.
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